Oncology and Hematology
17-32 of 592
- On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
- On the Frontlines of Metastatic Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
Pavani Chalasani, MD, MPH
Kristina Fanucci, MD, MHS
Jennifer Caudle, DO, FACOFP
Maxwell Llyod, MD
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
- Clinician's Roundtable
How COVID-19 mRNA Vaccination Restores Sensitivity to Immune Checkpoint Inhibitors
Charles Turck, PharmD, BCPS, BCCCP
Andrea Necchi, MD
- Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS
Nicholas Whipple, MD, MPH
Pavani Chalasani, MD, MPH
Timothy Yap, MBBS, PhD, FRCP
Seth Wander, MD, PhD
- On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
Marlene Mimi Maeusli, PhD.
